Tandem Diabetes (TNDM) Tops Q3 EPS by 15c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Tandem Diabetes Care Reports Third Quarter 2015 Financial Results
October 29, 2015 4:06 PM EDTSAN DIEGO, Oct. 29, 2015 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:flex® and t:slim G4 Insulin Pumps, today reported its financial results for the quarter ended September 30, 2015.Â
In comparing the third quarter of 2015 to the same period of 2014:
Sales grew 16 percent to $15.7 million from $13.5 million Pump shipments grew 17 percent to 3,431 pumps from 2,935 pumps Operating margin improved to negative 119 percent from negative 141 percentIn comparing the nine months ended September 30, 2015 to the same period of... More
